Barry, what you gonna do now?

Quote
anonymous said:
He's going to have to raise more money at some point in the next few months. Last I did the math, we are going to run out of money within the next 12-15 months. I know they are saying that we'll burn less and less each month or quarter going forward, and that we'll have enough cash for well beyond 12-15 months, but I just don't find that realistic at all. When I look around, i see more money being spent, not less and it's not like we we are selling all that much more than we did earlier this year. The CINV business is stagnant at best. Zynrelef will ramp but not to some magical extent that outpaces the amount of commercial resources we are putting behind it at this point. And nobody ever seems to talk about this but our gross margins are terrible! That's what happens when your strategy is to basically try to undercut competition on price. It didn't work for CINV, and TBD if it works on Zynrelef. But it sure as heck doesn't seem to be a winning long-term strategy when you are only keeping like 50 cents on every dollar of a drug you sell. That's what generic drug companies do but the difference is that they don't have to pay an entire sales force to drive demand in the field. It's truly amazing how our CEO has been able to keep his job after so many years of missteps and eroding shareholder value.
Click to expand...

Well said! They say the truth will set you free. Its time the BOD acts and replaces the inept leadership in this company. A lot of people took a risk joining this company, the least the company can do in return is be truthful and fair. Field Managers are awful, IDN team has done nothing, and money is going to run out sooner rather then later. The time for change is now.
 






anonymous said:
Well said! They say the truth will set you free. Its time the BOD acts and replaces the inept leadership in this company. A lot of people took a risk joining this company, the least the company can do in return is be truthful and fair. Field Managers are awful, IDN team has done nothing, and money is going to run out sooner rather then later. The time for change is now.
Click to expand...

BQ is Chairman of the BOD and he isn’t going to fire himself (although he should). No others on the BOD have any power or directly represent large holders, they’re all hacks as well. Tang bailed to go drive his other businesses into the toilet as well so basically there are no adults minding the store. Unless a large owner or activist takes interest, this will continue to be decimated by this management team’s incompetence which the short sellers feast on.

My question is, why are the employees still here? Oh that’s right - you’re also incompetent and part of the problem.
 






When nothing is enough you know it’s time to quit. In the past 1 year company has done Two rounds of layoffs, Sus back to selling, Cin performing better than anticipated, Zen launch, Zen label expansion, Cin in PONV.

Despite of all this stock price has gone down from $20 to $9. So you know investors (smart people) have given up on Heron and there is very little that can be done to turn this around with existing leadership. They are just filling their pockets knowing there is no future. Time to quit and end this misery.
 






anonymous said:
When nothing is enough you know it’s time to quit. In the past 1 year company has done Two rounds of layoffs, Sus back to selling, Cin performing better than anticipated, Zen launch, Zen label expansion, Cin in PONV.

Despite of all this stock price has gone down from $20 to $9. So you know investors (smart people) have given up on Heron and there is very little that can be done to turn this around with existing leadership. They are just filling their pockets knowing there is no future. Time to quit and end this misery.
Click to expand...

You chuckleheads need to do what your neighbors across the the street at Mirati did and hire a better CEO to drive commercialization of your products including global expansion or just sell the damn company. Barry can stay on as head of R&D - that the only thing he’s good at. He is not CEO material plus he’s a little long in the tooth.
 






anonymous said:
You chuckleheads need to do what your neighbors across the the street at Mirati did and hire a better CEO to drive commercialization of your products including global expansion or just sell the damn company. Barry can stay on as head of R&D - that the only thing he’s good at. He is not CEO material plus he’s a little long in the tooth.
Click to expand...

Barry has been CEO for 10 years and the stock price is exactly where it was when he started (after multiple raises). In investor/Wall Street speak we call that a FAILURE.

Embarrassing that the BOD hasn’t fired him yet. It’s like you all work for a family business or something.

But I guess it will be better tomorrow. Tomorrow, tomorrow, there’s always tomorrow, it’s only a day away….
 






At Ardea Barry was a good head of R&D
At Heron for his first 5 years, he was CEO in name only - Kevin was pulling all the strings. Still, as CEO he was a great head of R&D
Now that he's Chairman of the Board, he is still a great head of R&D.

The guy has been over his head for a good while. Problem is that Kevin is no longer pulling the strings - he's a marionette without an operator. Sleepwalking through his failed management style with no one kicking his a** like in the past.

The continuing strategy of trying to run everything because he can't manage in a greater way, disempowering every other employee by making all the decisions for them, and making sure that the sheep are the ones who stay to the bitter end has been a formula that worked twice - Agouron and Ardea. The formula doesn't work so well at Heron....

He has "alternate facts" on everything, shareholders who in the past knew all he does is lie, but still made a lot of money on him in the past, are starting to figure out that maybe the first two won't repeat a third time.
 






anonymous said:
At Ardea Barry was a good head of R&D
At Heron for his first 5 years, he was CEO in name only - Kevin was pulling all the strings. Still, as CEO he was a great head of R&D
Now that he's Chairman of the Board, he is still a great head of R&D.

The guy has been over his head for a good while. Problem is that Kevin is no longer pulling the strings - he's a marionette without an operator. Sleepwalking through his failed management style with no one kicking his a** like in the past.

The continuing strategy of trying to run everything because he can't manage in a greater way, disempowering every other employee by making all the decisions for them, and making sure that the sheep are the ones who stay to the bitter end has been a formula that worked twice - Agouron and Ardea. The formula doesn't work so well at Heron....

He has "alternate facts" on everything, shareholders who in the past knew all he does is lie, but still made a lot of money on him in the past, are starting to figure out that maybe the first two won't repeat a third time.
Click to expand...

Well said. The emperor is a short, mustache twirling dweeb with no clothes and there is nobody to kick his ass as you say to right the ship. As a result, EVERYBODY suffers. Patients, shareholders and employees.

But make no mistake, everybody understands what a debacle this is and nobody from other companies that know the story will be taking any of the suck up c players from this company when it finally comes to the end. If you don’t have the talent and brains to jump while the market is hot, you just don’t have talent or brains.
 






anonymous said:
At Ardea Barry was a good head of R&D
At Heron for his first 5 years, he was CEO in name only - Kevin was pulling all the strings. Still, as CEO he was a great head of R&D
Now that he's Chairman of the Board, he is still a great head of R&D.

The guy has been over his head for a good while. Problem is that Kevin is no longer pulling the strings - he's a marionette without an operator. Sleepwalking through his failed management style with no one kicking his a** like in the past.

The continuing strategy of trying to run everything because he can't manage in a greater way, disempowering every other employee by making all the decisions for them, and making sure that the sheep are the ones who stay to the bitter end has been a formula that worked twice - Agouron and Ardea. The formula doesn't work so well at Heron....

He has "alternate facts" on everything, shareholders who in the past knew all he does is lie, but still made a lot of money on him in the past, are starting to figure out that maybe the first two won't repeat a third time.
Click to expand...

If Barry could hire talented people and execute as well as he lies to everybody this company would be sold by now for $50+.
 












anonymous said:
Barry is a terrible CEO.

That’s it. That’s my post.
Click to expand...

Yes, this is true but it’s not just Barry or Heron. The whole small cap biotech sector is led by incompetent CEOs. There has just been too much easy money flowing to mediocre ideas and unproven leadership teams for years. San Diego in particular is a hotbed of such companies and management buffoons. If they only realized their own limitations they would beg BP to buy them for realistic prices.
 






QUOTE="anonymous, post: 6658833"]Yes, this is true but it’s not just Barry or Heron. The whole small cap biotech sector is led by incompetent CEOs. There has just been too much easy money flowing to mediocre ideas and unproven leadership teams for years. San Diego in particular is a hotbed of such companies and management buffoons. If they only realized their own limitations they would beg BP to buy them for realistic prices.[/QUOTE]

Wow that was a terrible ER. This entire Mgmt team needs to be fired for pure incompetence. How embarrassing.
 






Top Bottom
Back
Quote